Susquehanna International Group, LLP Biocept Inc Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.47 - $0.89 $19,129 - $36,223	-40,700 Reduced 71.53%	16,200 $8,000
Q3 2022 Nov 14, 2022	SELL	$0.75 - $1.2 $3,525 - $5,640	-4,700 Reduced 7.63%	56,900 $52,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $2.27 $10,032 - $25,878	11,400 Added 22.71%	61,600 $58,000
Q1 2022 May 16, 2022	SELL	$1.83 - $3.97 $46,299 - $100,441	-25,300 Reduced 33.51%	50,200 $116,000
Q4 2021 Feb 14, 2022	SELL	$3.43 - $4.22 $107,359 - $132,086	-31,300 Reduced 29.31%	75,500 $273,000
Q3 2021 Nov 15, 2021	BUY	$3.39 - $4.34 $142,041 - $181,846	41,900 Added 64.56%	106,800 $428,000
Q2 2021 Aug 11, 2021	BUY	$4.03 - $5.07 $74,152 - $93,288	18,400 Added 39.57%	64,900 $272,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.94 $150,258 - $251,698	31,700 Added 214.19%	46,500 $237,000
Q4 2020 Feb 16, 2021	BUY	$4.31 - $6.16 $63,787 - $91,168	14,800 New	14,800 $66,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.